US OptionsDetailed Quotes
BHC250516P8000
- 2.98
- 0.000.00%
15min DelayTrading May 12 09:50 ET
2.98High2.98Low
2.98Open2.98Pre Close2 Volume0 Open Interest8.00Strike Price596.00Turnover285.83%IV-4.69%PremiumMay 16, 2025Expiry Date3.21Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9422Delta0.0820Gamma1.34Leverage Ratio-0.0171Theta-0.0006Rho-1.26Eff Leverage0.0006Vega
Bausch Health Stock Discussion
Sign in to post a comment
Morning Movers
Gapping Up
$Alibaba (BABA.US)$ shares rose over 9% premarket after Alibaba reported better-than-anticipated third-quarter revenue. Strong online sales and robust e-commerce performance boosted investor sentiment amid a competitive market.
$Bausch Health (BHC.US)$ shares surged over 4% premarket following better-than-expected Q4 results. A 6% revenue rise and a 9% organic increase, along with guidance that exceeded co...
Gapping Up
$Alibaba (BABA.US)$ shares rose over 9% premarket after Alibaba reported better-than-anticipated third-quarter revenue. Strong online sales and robust e-commerce performance boosted investor sentiment amid a competitive market.
$Bausch Health (BHC.US)$ shares surged over 4% premarket following better-than-expected Q4 results. A 6% revenue rise and a 9% organic increase, along with guidance that exceeded co...
Expand 32
4
23
Bausch Health Responds to Market Rumors.
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) recently found itself at the center of market rumors that suggested the company was considering bankruptcy or insolvency proceedings. These rumors originated from an article issued by Reorg®, citing unnamed sources. In response, Bausch Health has categorically denied these claims, emphasizing that they are unsubstantiated and without merit...
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) recently found itself at the center of market rumors that suggested the company was considering bankruptcy or insolvency proceedings. These rumors originated from an article issued by Reorg®, citing unnamed sources. In response, Bausch Health has categorically denied these claims, emphasizing that they are unsubstantiated and without merit...
Bausch Health's revenue growth is unimpressive due to its lack of profitability. The share price crash may be an over-reaction, but improvements in business fundamentals are needed before considering a purchase. The company's long-term performance is concerning, and clear growth indicators are required for share price stability.
2
News Highlights
$Tesla (TSLA.US)$ shares fell by 3.63%, closing at $164.90. Its options trading volume was 3.83 million. Call contracts account for 48.3% of the total trading volume. The most traded calls are contracts of $170 strike price that expire on Apr. 5th. The total volume reaches 106,470 with an open interest of 29,026. The most traded puts are contracts of a $165 strike p...
$Tesla (TSLA.US)$ shares fell by 3.63%, closing at $164.90. Its options trading volume was 3.83 million. Call contracts account for 48.3% of the total trading volume. The most traded calls are contracts of $170 strike price that expire on Apr. 5th. The total volume reaches 106,470 with an open interest of 29,026. The most traded puts are contracts of a $165 strike p...
45
24
48
In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions (EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...
The company’s turnaround efforts appear to be receiving a jolt today, wit...
8
1
1
$Bausch Health (BHC.US)$
Entered BHC. SL below ytd’s low.
Entered BHC. SL below ytd’s low.
1
1
No comment yet
73164454 : Staying away from China Stocks is not an issue with any company, but rather due to uncertainty.
105742796 Learner : Stock volatility
New plans new forecast
Revenue release
SPICYDOC辣刀客 73164454 : IS there any certainty with any stocks unless insider information? Two things certain about Chinese stocks are low valuation, and determination to bottom up with government support.
Laine Ford : I say no more talk to yall now